LAM
MLAB icon

L2 Asset Management’s Mesa Laboratories MLAB Stock Holding History

L2 Asset Management’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-20,192
Closed -$1.37K – 213
2023
Q3 		$1.37K Buy
+20,192
New +$2.59M ﹤0.01% 204

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

L2 Asset Management's MLAB Position: Q4 2023 in Review

L2 Asset Management sold out of Mesa Laboratories (MLAB) in Q4 2023, closing a stake of 20,192 shares — an estimated $1.37K sold.

L2 Asset Management first reported a position in MLAB in Q3 2023 and held it in 1 quarter. The position peaked at $1.37K in Q3 2023. 158 funds tracked by Wall St. Rank hold MLAB as of Q4 2023.

  • L2 Asset Management reported no remaining Mesa Laboratories position as of Q4 2023 after selling out during the quarter.
  • L2 Asset Management sold 20,192 Mesa Laboratories shares in Q4 2023, an estimated $1.37K.
  • L2 Asset Management first reported a position in Mesa Laboratories in Q3 2023 and held it in 1 quarter.
  • L2 Asset Management's Mesa Laboratories position peaked at $1.37K in Q3 2023.
  • 158 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2023.

Based on L2 Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.